Medi Siddh Pharma Private Limited

Medi Siddh Pharma Private Limited - healthcare in Kovilpatti, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U33112TN1989PTC017917 Incorporated 18 August 1989 ROC Chennai HQ Kovilpatti, Tamil Nadu, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2025
₹4.59 Cr
▲ 5% YoY
Net loss · FY 2025
₹1.06 Cr
Net margin -23%
EBITDA · FY 2025
-₹89.74 Lakh
EBITDA margin -19.5%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹43 Lakh
Issued & subscribed
Open charges
₹15.76 Lakh
Secured borrowings
Company age
37 yrs
Est. 1989
Employees · EPFO
45
Provident fund records

About Medi Siddh Pharma Private Limited

Data last updated:

Medi Siddh Pharma Private Limited is a private limited company based in Kovilpatti, Tamil Nadu, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 18 August 1989 and has been in existence for over 37 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U33112TN1989PTC017917. Its GSTIN is 33AAACM2416K1ZS (Tamil Nadu).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹43 Lakh. It is led by directors including Alaguraj and Subbulakshmi Sundrarajan.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 971A/6 Thirumal Nagar Near K. R. Arts College Nh7, Kovilpatti, Tamil Nadu, India – 628503.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.59 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net loss of ₹1.06 Cr (net margin -23%) and EBITDA of -₹89.74 Lakh (EBITDA margin -19.5%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 36% over five years.

The company has about 45 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹15.76 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medisiddh.in.

Company details

CIN U33112TN1989PTC017917
Registration Number 017917
Incorporation Date 18 August 1989
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Medi Siddh Pharma Private Limited's registered office is in Kovilpatti, Tamil Nadu. Its website is medisiddh.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    971A/6 Thirumal Nagar Near K. R. Arts College Nh7, Kovilpatti, Tamil Nadu, India – 628503
  • Industry
    Healthcare, Ayurvedic Products & Services

To see the full contact details of Medi Siddh Pharma Private Limited, buy the company report.

Comprehensive company report
Medi Siddh Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Medi Siddh Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Medi Siddh Pharma Private Limited, buy the company report.

Financials of Medi Siddh Pharma Private Limited

FY 2025 filings available

Medi Siddh Pharma Private Limited reported revenue of ₹4.59 Cr (up 5% YoY) for FY 2025.

Revenue · FY 2025
₹4.59 Cr ▲ 5%
Net loss · FY 2025
₹1.06 Cr margin -23%
EBITDA · FY 2025
-₹89.74 Lakh margin -19.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 1%
5 years · compounded
▲ 36%
EBITDA CAGR growth
3 years · compounded
▼ 37%
5 years · compounded
▲ 12%

Revenue has grown at a compounded annual rate (CAGR) of 36% over five years, including 5% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹89.74 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.06 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-19.5%
Net Profit Margin-23%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medi Siddh Pharma Private Limited, buy the company report.

Board of directors of Medi Siddh Pharma Private Limited

Medi Siddh Pharma has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
AlagurajDirector07 Aug 201214 Years 2 MonthsCurrent
Subbulakshmi SundrarajanDirector27 Dec 20178 Years 10 MonthsCurrent
Rajkumar SundararajanDirector18 Dec 20178 Years 10 MonthsCurrent
Murugan GanapathyDirector24 Jul 20251 Years 3 MonthsCurrent

Peer comparison

Medi Siddh Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Vishwa Holistic Solutions Private Limited₹4.7 Cr (FY 2025)-30.0%Pune, Maharashtra, India
Wilson Drugs and Pharmaceuticals Pvt Ltd₹4.7 Cr (FY 2025)-1.0%Jalandhar, Punjab, India
Shri Ayurved Seva Sadan Private Limited₹4.65 Cr (FY 2024)3.0%Firozabad, Uttar Pradesh, India
Medi Siddh Pharma Private Limitedthis company₹4.59 Cr (FY 2025)-₹1.06 Cr-23%5.0%45Kovilpatti, Tamil Nadu, India
V C Pharmaceuticals (India) Private Limited₹4.48 Cr (FY 2025)1.0%Paravur, Kerala, India

To see the full peer comparison of Medi Siddh Pharma Private Limited, buy the company report.

Auditor

Medi Siddh Pharma Private Limited is audited by MAHALINGAM & SRIVATSAN for the financial year 2022.

Auditor firmFinancial yearFirm registration number
MAHALINGAM & SRIVATSANFY 2022001929S

Shareholding

The shareholding of Medi Siddh Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Medi Siddh Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹15.76 Lakh
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹0.15 Cr
Bank of Madurai Ltd.₹0.01 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 Jun 2021100466605Hdfc Bank Limited₹14.69 LakhOpen
08 Jun 199090304486Bank of Madurai Ltd.₹1.07 LakhOpen

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medi Siddh Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Medi Siddh Pharma Private Limited has a workforce of 45 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.

Employee count
45
Active EPFO establishments
1
Employee growth
-11.76%

GST

Medi Siddh Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AAACM2416K1ZSTamil NaduActive01 Jul 2017

To see the full GST registrations and return filing status of Medi Siddh Pharma Private Limited, buy the company report.

Recent activity

Medi Siddh Pharma Private Limited has 10 board changes on record since 2012: 4 appointments and 6 cessations. The latest: Murugan Ganapathy was appointed as Director on 24 Jul 2025.

AGM
Medi Siddh Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Murugan Ganapathy was appointed as Director.
Filing
Medi Siddh Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 14.69 Lakh with Charge ID 100466605 was registered on 28 Jun 2021.
Ceased
Rajkumar Sundararajan ceased to be Additional Director.
Appointed
Subbulakshmi Sundrarajan was appointed as Director.
Appointed
Rajkumar Sundararajan was appointed as Director.
Ceased
Subbulakshmi Sundrarajan ceased to be Additional Director.
Ceased
Subburaj Ramesh ceased to be Additional Director.
Ceased
Veluchamy Gopalsamy ceased to be Director.
Ceased
Veluchamy Ponnammal ceased to be Managing Director.
Appointed
Alaguraj was appointed as Director.

3 earlier events are in the company report.

Frequently asked questions

Medi Siddh Pharma is an active private limited company based in Kovilpatti, Tamil Nadu, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 18 August 1989 (37+ years old) and is registered under CIN U33112TN1989PTC017917.

Medi Siddh Pharma has 4 current directors:

The latest financial statements of Medi Siddh Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Medi Siddh Pharma is 33AAACM2416K1ZS, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Medi Siddh Pharma is U33112TN1989PTC017917. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medi Siddh Pharma was incorporated on 18 August 1989, making it 37+ years old. It is registered with the Registrar of Companies, Chennai.

The peers of Medi Siddh Pharma by revenue are Vishwa Holistic Solutions Private Limited, Wilson Drugs and Pharmaceuticals Pvt Ltd, Shri Ayurved Seva Sadan Private Limited, V C Pharmaceuticals (India) Private Limited, all in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Murugan Ganapathy was appointed as Director on 24 Jul 2025. Rajkumar Sundararajan ceased to be Additional Director on 30 Sep 2018. Subbulakshmi Sundrarajan was appointed as Director on 27 Dec 2017. Medi Siddh Pharma has 10 board changes on record in total.

Medi Siddh Pharma can be reached through the website medisiddh.in. Its registered office is in Kovilpatti, Tamil Nadu, India.

The registered office of Medi Siddh Pharma is at 971A6 Thirumal Nagar Near K. R. Arts College Nh7, Kovilpatti, Tamil Nadu, India – 628503.

Medi Siddh Pharma operates in the healthcare industry, in the ayurvedic products and services segment.